Mulig daptomycininduceret pneumoni

Ugeskrift for Laeger

Volumn 172, Issue 32, 2010, Pages 2172-2174

  Søndergaard, Turid Snekloth ^a   Schumacher, Helga ^a   Norup, Kirsten ^a  

^a HERNING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE; DAPTOMYCIN;

AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; ENTEROCOCCUS FAECALIS; EOSINOPHILIA; HUMAN; MALE; MICROBIOLOGY; PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DAPTOMYCIN; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; EOSINOPHILIA; HUMANS; MALE; PNEUMONIA;

EID: 77956091166     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Cottagnoud P. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens. Swiss Med Wkly 2008;138:93-9.
2. Kakish E, Wiesner AM, Winstead PS et al. Acute respiratory failure due to daptomycin induced eosinophilic pneumonia. Respiratory Medicine CME 2008;1: 235-7.
3. Cobb E, Kimbrough RC, Nugent KM et al. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin. Ann Pharmacother 2007;41:696-701.
4. Solomon J, Schwartz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 2006;27:192-7.
5. Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004;25:37-45.